Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics

Addiction

Volumn 108, Issue 2, 2013, Pages 394-403

  Ward, Kenneth D ^a,b   Asfar, Taghrid ^b,c   Al Ali, Radwan ^b   Rastam, Samer ^b,d   Weg, Mark W Vander ^e,f,g   Eissenberg, Thomas ^b,h   Maziak, Wasim ^b,i  

^a UNIVERSITY OF MEMPHIS   (United States)

^b SYRIAN CENTER FOR TOBACCO STUDIES   (Syrian Arab Republic)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

^e UNIVERSITY OF IOWA   (United States)

^f E11 SSH   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

ⁱ FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Effectiveness; Nicotine patch; Primary care; Randomized controlled trial; Smoking; Syria

Indexed keywords

CARBON MONOXIDE; NICOTINE; NICOTINE GUM;

ADOLESCENT; ADULT; AGED; BEHAVIOR, ADDICTIVE; CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; OUTPATIENT DEPARTMENT; PREVENTION AND CONTROL; PRIMARY HEALTH CARE; PROCEDURES; PROGRAM EVALUATION; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SMOKING; SMOKING CESSATION; SYRIAN ARAB REPUBLIC; TREATMENT OUTCOME; YOUNG ADULT; ADDICTION; ARTICLE; CONTROLLED CLINICAL TRIAL; METHODOLOGY;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; AMBULATORY CARE FACILITIES; BEHAVIOR, ADDICTIVE; CARBON MONOXIDE; COUNSELING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PRIMARY HEALTH CARE; PROGRAM EVALUATION; SELF REPORT; SMOKING; SMOKING CESSATION; SYRIA; TOBACCO USE CESSATION PRODUCTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872527594     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.04048.x     Document Type: Article

References (48)

1. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2009: Implementing Smoke-Free Environments. Geneva, Switzerland: World Health Organization; 2009.
2. Ward K. D., Eissenberg T., Rastam S., Asfar T., Mzayek F., Fouad M. F. etal. The tobacco epidemic in Syria. Tob Control 2006; 15: i24-29.
3. Maziak W. Smoking in Syria: profile of a developing Arab country. Int J Tuberc Lung Dis 2002; 6: 183-191.
4. Asfar T., Vander Weg M. W., Maziak W., Hammal F., Eissenberg T., Ward K. D. Outcomes and adherence in Syria's first smoking cessation trial. Am J Health Behav 2008; 32: 146-156.
5. Maziak W., Eissenberg T., Klesges R. C., Keil U., Ward K. D. Adapting smoking cessation interventions for developing countries: a model for the Middle East. Int J Tuberc Lung Dis 2004; 8: 403-413.
6. Asfar T., Al-Ali R., Ward K. D., Vander Weg M. W., Maziak W. Are primary health care providers prepared to implement an anti-smoking program in Syria?, Patient Educ Couns 2011; 85: 201-205.
7. Maziak W., Ward K. D., Eissenberg T., Klesges R. C., Keil U. The Syrian Center for Tobacco Studies: a model of international partnership for the creation of sustainable research capacity in developing countries. Promot Educ 2004; 11: 93-97. 116, 134.
8. Fiore M. C., Jaén C. R., Baker T. B., Bailey W. C., Benowitz N. L., Curry S. J. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service; 2008.
9. Kottke T. E., Battista R. N., Defriese G. H., Brekke M. L. Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. JAMA 1988; 259: 2883-2889.
10. Abrams D. B., Niaura R., Brown R. A., Emmons K. M., Goldstein M. G., Monti P. M. The Tobacco Dependence Treatment Handbook: A Guide to Best Practices. New York: Guilford Press; 2003.
11. Hughes J. R., Keely J. P., Niaura R. S., Ossip-Klein D. J., Richmond R. L., Swan G. E. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003; 5: 13-25.
12. West R., Hajek P., Stead L., Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005; 100: 299-303.
13. Biener L., Abrams D. B. The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol 1991; 10: 360-365.
14. Velicer W. F., Diclemente C. C., Rossi J. S., Prochaska J. O. Relapse situations and self-efficacy: an integrative model. Addict Behav 1990; 15: 271-283.
15. Heatherton T. F., Kozlowski L. T., Frecker R. C., Fagerstrom K. O. The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addict 1991; 86: 1119-1127.
16. Zimet G. D., Dahlem N. W., Zimet S. G., Farley G. K. The multidimensional scale of perceived social support. J Pers Assess 1988; 52: 30-41.
17. Zimet G. D., Powell S. S., Farley G. K., Werkman S., Berkoff K. A. Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. J Pers Assess 1990; 55: 610-617.
18. Radloff L. D. The CES-D: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
19. Thomas J. L., Jones G. N., Scarinci I. C., Mehan D. J., Brantley P. J. The utility of the CES-D as a depression screening measure among low-income women attending primary care clinics. The Center for Epidemiologic Studies-Depression. Int J Psychiatry Med 2001; 31: 25-40.
20. Hughes J. R., Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 1986; 43: 289-294.
21. Hughes J. R., Wadland W. C., Fenwick J. W., Lewis J., Bickel W. K. Effect of cost on the self-administration and efficacy of nicotine gum: a preliminary study. Prev Med 1991; 20: 486-496.
22. Hughes J., Hatsukami D. K. Errors in using tobacco withdrawal scale. Tob Control 1998; 7: 92-93.
23. Ferguson J., Bauld L., Chesterman J., Judge K. The English smoking treatment services: one-year outcomes. Addiction 2005; 100: 59-69.
24. Baillie A. J., Mattick R. P., Hall W. Quitting smoking: estimation by meta-analysis of the rate of unaided smoking cessation. Aust J Public Health 1995; 19: 129-131.
25. Ward K. D., Klesges R. C., Zbikowski S. M., Bliss R. E., Garvey A. J. Gender differences in the outcome of an unaided smoking cessation attempt. Addict Behav 1997; 22: 521-533.
26. Hughes J. R., Keely J., Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004; 99: 29-38.
27. Dale L. C., Hurt R. D., Offord K. P., Lawson G. M., Croghan I. T., Schroeder D. R. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation. JAMA 1995; 274: 1353-1358.
28. Fagerstrom K. O., Schneider N. G., Lunell E. Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology (Berl) 1993; 111: 271-277.
29. Levin E. D., Westman E. C., Stein R. M., Carnahan E., Sanchez M., Herman S. etal. Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking. J Clin Psychopharmacol 1994; 14: 41-49.
30. Rose J. E., Behm F. M. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments. Nicotine Tob Res 2004; 6: 523-532.
31. Stead L. F., Perera R., Bullen C., Mant D., Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008; 1: CD000146.
32. Schneider N. G., Cortner C., Gould J. L., Koury M. A., Olmstead R. E. Comparison of craving and withdrawal among four combination nicotine treatments. Hum Psychopharmacol 2008; 23: 513-517.
33. Smith S. S., Mccarthy D. E., Japuntich S. J., Christiansen B., Piper M. E., Jorenby D. E. etal. Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Arch Intern Med 2009; 169: 2148-2155.
34. Rose J. E., Herskovic J. E., Behm F. M., Westman E. C. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment. Nicotine Tob Res 2009; 11: 1067-1075.
35. Shiffman S., Ferguson S. G. Nicotine patch therapy prior to quitting smoking: a meta-analysis. Addiction 2008; 103: 557-563.
36. Mooney M., White T., Hatsukami D. The blind spot in the nicotine replacement therapy literature: assessment of the double-blind in clinical trials. Addict Behav 2004; 29: 673-684.
37. Perkins K. A., D'amico D., Sanders M., Grobe J. E., Wilson A., Stiller R. L. Influence of training dose on nicotine discrimination in humans. Psychopharmacology (Berl) 1996; 126: 132-139.
38. Hughes J. R., Hatsukami D. K., Pickens R. W., Krahn D., Malin S., Luknic A. Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology (Berl) 1984; 83: 82-87.
39. Etter J. F., Burri M., Stapleton J. The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta-analysis. Addiction 2007; 102: 815-822.
40. Alpert H. R., Connolly G. N., Biener L. A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tob Control 2012. Epub ahead of print.
41. Hughes J. R., Shiffman S., Callas P., Zhang J. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control 2003; 12: 21-27.
42. Hughes J. R., Peters E. N., Naud S. Effectiveness of over-the-counter nicotine replacement therapy: a qualitative review of nonrandomized trials. Nicotine Tob Res 2011; 13: 512-522.
43. Walsh R. A. Over-the-counter nicotine replacement therapy: a methodological review of the evidence supporting its effectiveness. Drug Alcohol Rev 2008; 27: 529-547.
44. Hyland A., Rezaishiraz H., Giovino G., Bauer J. E., Michael Cummings K. Over-the-counter availability of nicotine replacement therapy and smoking cessation. Nicotine Tob Res 2005; 7: 547-555.
45. West R., Zhou X. Is nicotine replacement therapy for smoking cessation effective in the 'real world'? Findings from a prospective multinational cohort study. Thorax 2007; 62: 998-1002.
46. Kishore S. P., Bitton A., Cravioto A., Yach D. Enabling access to new WHO essential medicines: the case for nicotine replacement therapies. Global Health 2010; 6: 22.
47. Raw M., Regan S., Rigotti N. A., Mcneill A. A survey of tobacco dependence treatment guidelines in 31 countries. Addiction 2009; 104: 1243-1250.
48. Alberg A. J., Stashefsky Margalit R., Burke A., Rasch K. A., Stewart N., Kline J. A. etal. The influence of offering free transdermal nicotine patches on quit rates in a local health department's smoking cessation program. Addict Behav 2004; 29: 1763-1778.